Universe Pharmaceuticals (UPC) CEO lists 3,467 Class B shares

Rhea-AI Filing Summary

Universe Pharmaceuticals INC director and Chief Executive Officer Lai Gang has filed an initial Form 3 reporting his beneficial ownership in the company. The filing shows indirect ownership of 3,467 Class B ordinary shares, par value US$0.00001 per share, held through Sununion Holding Group Limited, a British Virgin Islands company that is 100% owned and controlled by him.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Lai Gang

Role Chief Executive Officer

Type	Security	Shares	Price	Value
holding	Class B ordinary shares, par value US$0.00001 per share	--	--	--

Holdings After Transaction: Class B ordinary shares, par value US$0.00001 per share — 3,467 shares (Indirect, By Sununion Holding Group Limited)

Footnotes (1)

1. [object Object]

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Accepted by SEC EDGAR 03/18/2026 - 08:26 AM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Lai Gang

(Last) (First) (Middle)

265 JINGJIU AVENUE

JINGGANGSHAN ECON. AND TECH. DEV. ZONE

(Street)

JI'AN, JIANGXI 343100

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Universe Pharmaceuticals INC [ UPC ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class B ordinary shares, par value US$0.00001 per share	3,467	I	By Sununion Holding Group Limited(1)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents 3,467 Class B ordinary shares held by Sununion Holding Group Limited, a business company incorporated in the British Virgin Islands, which is owned as to 100% and controlled by Gang Lai. The registered address of Sununion Holding Group Limited is Vistra Corporate Services Centre, Wickhams Cay II, Road Town, Tortola, VG1110, British Virgin Islands.

	/s/ Gang Lai	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Universe Pharmaceuticals (UPC) CEO Lai Gang report in this Form 3?

CEO and director Lai Gang reports his beneficial ownership in Universe Pharmaceuticals on Form 3. He discloses an indirect position of 3,467 Class B ordinary shares held through Sununion Holding Group Limited, reflecting his initial ownership status as an insider.

How many Universe Pharmaceuticals UPC shares does Lai Gang beneficially own on this Form 3?

The Form 3 shows Lai Gang beneficially owns 3,467 Class B ordinary shares. These shares are not held directly in his name but through Sununion Holding Group Limited, which the filing states is 100% owned and controlled by him.

How are Lai Gang’s Universe Pharmaceuticals UPC shares held according to the filing?

The filing states the 3,467 Class B ordinary shares are held by Sununion Holding Group Limited. This entity is a British Virgin Islands business company that is owned as to 100% and controlled by Lai Gang, making his ownership indirect.

What class of Universe Pharmaceuticals UPC shares does the Form 3 cover?

The Form 3 covers Class B ordinary shares of Universe Pharmaceuticals, with a par value of US$0.00001 per share. It reports 3,467 such Class B ordinary shares beneficially owned indirectly by CEO and director Lai Gang through Sununion Holding Group Limited.

Is Lai Gang’s ownership in Universe Pharmaceuticals UPC direct or indirect?

The ownership reported is indirect. The Form 3 specifies that the 3,467 Class B ordinary shares are held by Sununion Holding Group Limited, with the nature of ownership marked as indirect and the entity being fully owned and controlled by Lai Gang.